Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
The bivalent vaccine booster outperforms - by Eric Topol
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
A quick update on the bivalent boosters - by Eric Topol
Why payers should be preparing now for new COVID-19 boosters
Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged ≥50 years in Ontario, Canada | medRxiv
New Omicron-specific vaccines offer similar protection to existing boosters
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines | The Scientist Magazine®
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog
COVID-19 bivalent booster effectiveness in people with and without immune dysfunction L
DPH Shares Monthly COVID-19 Update, Announces Changes to Data Reporting and Booster Guidance - State of Delaware News
Let's discuss COVID-19 Bivalent Booster Effectiveness - ICAP
:max_bytes(150000):strip_icc()/Booster-Shot-GettyImages-1362497127-e10ca9b1e3e5424db126022a8dc254bf.jpg "How Effective Are the Bivalent Boosters? CDC Shares New Data")
How Effective Are the Bivalent Boosters? CDC Shares New Data
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study - The Lancet Infectious Diseases
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
New Omicron-specific vaccines offer similar protection to existing boosters
Real-world data show new Covid boosters increase protection
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine | Australian Government Department of Health and Aged Care
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
Effectiveness of Bivalent Boosters against Severe Omicron Infection | NEJM
Vaccines | Free Full-Text | Vaccine Confidence and Uptake of the Omicron Bivalent Booster in Tennessee: Implications for Vulnerable Populations
